ArticleFASEB bioAdvances2021

OX40-targeted immune agonist antibodies induce potent antitumor immune responses without inducing liver damage in mice.

Yee C Tee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.